|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.52 USD | -6.05% |
|
-29.43% | +1.53% |
| 31/07 | Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial | MT |
| 31/07 | Wedbush Adjusts Monte Rosa Therapeutics Price Target to $27 From $37, Maintains Outperform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 19.71 | 24.56 | 24.56 |
| Spread/Res. | -19.23% | -35.18% | -35.18% |
| Spread/Supp. | -2.75% | +8.15% | +53.67% |
| Support | 16.37 | 14.72 | 10.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GLUE Stock
- Charts Monte Rosa Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
